bpc-157 rapid - 250mcg BPC Capsules | BPC PRO BPC RAPID - 250MCG |

Mounjaro, FDA-approved for diabetes), and liraglutide (Saxenda)

Acknowledgements The work was supported by NEI R15EY029866-01 and a NASA DC Space Grant (to V.P.C.)

Peer-reviewed literature indexed on PubMed Reviews BPC-157 cardioprotective and cytoprotective mechanisms in preclinical models

While the anecdotal evidence supporting these benefits is strong, it's important to note that human clinical trials are limited, and the use of BPC 157 should be approached with caution, particularly in individuals with cancer risk due to its angiogenic properties

L., Dearman, L., Vardi, I

This product is intended to be handled solely by licensed and qualified professionals